Analyst Price Targets — AMRZ
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 8, 2026 10:57 am | — | Wells Fargo | $58.00 | $50.94 | TheFly | Amrize price target lowered to $58 from $65 at Wells Fargo |
| July 7, 2026 10:26 am | Keith Hughes | Truist Financial | $48.00 | $54.01 | TheFly | Amrize downgraded to Hold from Buy at Truist |
| June 22, 2026 3:53 pm | — | Morgan Stanley | $63.00 | $53.43 | TheFly | Amrize price target lowered to $63 from $65 at Morgan Stanley |
| May 6, 2026 1:16 pm | — | Morgan Stanley | $65.00 | $54.48 | TheFly | Amrize price target lowered to $65 from $69 at Morgan Stanley |
| May 1, 2026 12:41 pm | — | Oppenheimer | $68.00 | $53.38 | TheFly | Amrize price target lowered to $68 from $70 at Oppenheimer |
| May 1, 2026 11:45 am | — | Vertical Research | $70.00 | $53.78 | TheFly | Amrize upgraded to Buy from Hold at Vertical Research |
| April 15, 2026 10:58 am | Timna Tanners | Wells Fargo | $65.00 | $59.96 | TheFly | Amrize price target lowered to $65 from $66 at Wells Fargo |
| February 20, 2026 2:39 pm | — | Truist Financial | $75.00 | $65.00 | TheFly | Amrize price target raised to $75 from $60 at Truist |
| February 19, 2026 12:47 pm | — | Oppenheimer | $70.00 | $63.70 | TheFly | Amrize price target raised to $70 from $64 at Oppenheimer |
| February 19, 2026 11:38 am | Timna Tanners | Wells Fargo | $66.00 | $63.70 | TheFly | Amrize price target raised to $66 from $59 at Wells Fargo |
Latest News for AMRZ
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) will release its second quarter 2026 financial results after the U.S. market closes on Thursday, August 6, 2026, followed by a live webcast to discuss the company's financial results at 7:30 am Central Time on Friday, August 7, 2026. Registration for the live webcast can be completed at https://amrize-quarterly-results-q2-2026.open-exchange.net/ Amrize's…
Amrize is rated a cautious Buy, supported by strong Building Materials performance and a $1B buyback program. Building Materials delivered double-digit volume growth and margin expansion, driving operating leverage and supporting 8–11% adjusted EBITDA growth guidance. Building Envelope remains a weakness due to roofing headwinds, but resolved plant disruptions and price increases could enable a second-half recovery.
SAINT-CONSTANT, Quebec--(BUSINESS WIRE)--Amrize (NYSE: AMRZ) today broke ground on the modernization of its cement plant outside Montreal to be the most advanced and sustainable in Eastern Canada. As the largest investment in the Canadian cement industry over the last decade, the project will introduce state-of-the-art operational efficiency and enhanced sustainability, while expanding local manufacturing and…
Amrize AG remains a Buy as Building Materials drives robust organic volume growth and margin expansion, despite mixed Q1 2026 segment results. BM segment revenue rose 12.9% with cement and aggregates volumes up ~14%, while margin expanded 230 bps to 11.3%, signaling high-quality demand. Commercial demand drivers have broadened beyond data centers to include energy, warehousing, logistics, and multi-year project…
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) will start its previously announced share buyback program on May 6, 2026. The program has been authorized for a total of $1 billion USD until May 5, 2027, with the shares to be repurchased for the purpose of cancellation. The share buyback program will be executed on a second trading line on SIX Swiss Stock Exchange (Valor: 156 026 729 , ISIN: CH 156 026 729…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AMRZ.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.